B
Brian Skinnider
Researcher at University of British Columbia
Publications - 50
Citations - 2317
Brian Skinnider is an academic researcher from University of British Columbia. The author has contributed to research in topics: Lymphoma & ABVD. The author has an hindex of 20, co-authored 43 publications receiving 2070 citations. Previous affiliations of Brian Skinnider include BC Cancer Agency & Vancouver General Hospital.
Papers
More filters
Journal ArticleDOI
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
Pedro Farinha,Hamid Masoudi,Brian Skinnider,Karey Shumansky,John J. Spinelli,Karamjit Gill,Richard Klasa,N. J. Voss,Joseph M. Connors,Randy D. Gascoyne +9 more
TL;DR: The LAM content of FL predicts survival, and these data support a prominent role for nonneoplastic immune cells in the biology of FL.
Journal ArticleDOI
Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors.
Brian Skinnider,Andrew L. Folpe,Randolph A. Hennigar,So Dug Lim,Cynthia Cohen,Pheroze Tamboli,Andrew N. Young,Mariza de Peralta-Venturina,Mahul B. Amin +8 more
TL;DR: The purpose of this study was to determine the diagnostic utility of cytokeratin (CK) subtype expression pattern in a wide range of adult RENs and found that CK expression patterns may be useful in several differential diagnostic settings.
Journal ArticleDOI
International Prognostic Score in Advanced-Stage Hodgkin’s Lymphoma: Altered Utility in the Modern Era
Alden A. Moccia,Jane Donaldson,Mukesh Chhanabhai,Paul Hoskins,Richard Klasa,Kerry J. Savage,Tamara Shenkier,Graham W. Slack,Brian Skinnider,Randy D. Gascoyne,Joseph M. Connors,Laurie H. Sehn +11 more
TL;DR: The IPS remains prognostic for advanced-stage HL, but the range of outcomes has narrowed considerably, and an improvement in outcome with ABVD should be acknowledged before consideration of alternate initial therapies and when comparing results from current trials with those of historic controls.
Journal ArticleDOI
Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
TL;DR: The risk of transformation in patients with NLPHL to DLBCL is substantial and underappreciated and long-term follow-up of these individuals is necessary to accurately estimate the risk of development of secondaryDLBCL.
Journal ArticleDOI
Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.
Gladell P. Paner,John R. Srigley,Anuradha Radhakrishnan,Cynthia Cohen,Brian Skinnider,Satish K. Tickoo,Andrew N. Young,Mahul B. Amin +7 more
TL;DR: In tumors with predominant compact tubular growth and focal papillary architectures, careful attention to the presence of a low-grade spindle cell population may be helpful in the distinction of mucinous tubular and spindlecell carcinoma, as the key immunohistochemical stains for papillary renal cell carcinoma are also expressed in this subtype of renal cell cancer.